Metolazone (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Metolazone drug offered from Mylan Institutional Inc.. This Increased Diuresis [PE],Thiazide-like Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
NON-PROPRIETARY NAME: | metolazone |
SUBSTANCE NAME: | METOLAZONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Increased Diuresis [PE],Thiazide-like Diuretic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-04-15 |
END MARKETING DATE: | 0000-00-00 |
Metolazone HUMAN PRESCRIPTION DRUG Details:
Item Description | Metolazone from Mylan Institutional Inc. |
LABELER NAME: | Mylan Institutional Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2005-04-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51079-023_c42a0e21-15b8-4cbe-8625-6a8f5fd0c226 |
PRODUCT NDC: | 51079-023 |
APPLICATION NUMBER: | ANDA076698 |
Other METOLAZONE Pharmaceutical Manufacturers / Labelers: